Cost-Sharing Incentives Would Drive Higher Generic Drug Use By Low-Income Enrollees In Part D - MedPAC
This article was originally published in The Pink Sheet Daily
Executive Summary
Staff analysis found beneficiaries receiving subsidies have high brand use in categories where generics are available, including antipsychotics, diabetes, peptic ulcer treatment, cholesterol therapy.
You may also be interested in...
GPhA’s Deficit Reduction Proposals Focus On Medicare Low-Income Subsidy, REMS Policies
In letters to congressional leaders, generic drug trade group outlines six proposals that it says would save the government billions of dollars and lessen the impact of sequestration cuts.
MedPAC Considers Zero Copay On Generic Drugs For Low-Income Part D Beneficiaries
At its Nov. 3 meeting, the Medicare Payment Advisory Commission agreed with a staff proposal to legislate lower copays as a way to encourage greater use of generics among those receiving the low-income subsidy in Medicare Part D.
MedPAC Considers Zero Copay On Generic Drugs For Low-Income Part D Beneficiaries
At its Nov. 3 meeting, the Medicare Payment Advisory Commission agreed with a staff proposal to legislate lower copays as a way to encourage greater use of generics among those receiving the low-income subsidy in Medicare Part D.